Home » Unlabelled » Drug Information Update- FDA Drug Safety Communication: FDA requests label changes and single-use packaging for some over-the-counter topical antiseptic products to decrease risk of infection

Drug Information Update- FDA Drug Safety Communication: FDA requests label changes and single-use packaging for some over-the-counter topical antiseptic products to decrease risk of infection

FDA Division of Drug Information: Know the Moment It Happens

The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.

The U.S. Food and Drug Administration (FDA) is requesting label and packaging changes to enhance the safe use of certain over-the-counter (OTC) topical antiseptic products. This request is the result of our ongoing evaluation of infrequent but continuing reports of infections resulting from antiseptic products labeled for preoperative or preinjection skin preparation. When used properly, topical antiseptics are safe and effective products to reduce the number of bacteria on patients’ skin prior to surgery or injections. However, most often, contamination of topical antiseptics occurs when organisms are introduced into the product by users. Therefore, health care professionals and patients should follow all label directions to decrease the chances of infection.

For further information, please visit: OTC topical antiseptics.

This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO FDA (1-888-463-6332) or (301) 796-3400 from 8:00 am - 4:30 pm Monday - Friday. You can also email us at druginfo@fda.hhs.gov.

For additional drug information, please visit the DDI Web page.
For up-to-date drug information, follow the FDA’s Division of Drug Information on Twitter: FDA_Drug_Info
This service is provided to you at no charge by the U.S. Food & Drug Administration (FDA).

Subscriber Services:
Manage Preferences | Unsubscribe | Help with this service

Stay Connected:

This email was sent to aqeel.naseem87.Aqeel7879598@blogger.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420

Thank you for reading the article about Drug Information Update- FDA Drug Safety Communication: FDA requests label changes and single-use packaging for some over-the-counter topical antiseptic products to decrease risk of infection. If you want to duplicate this article you are expected to include links https://pharmacologyebooksdownload.blogspot.com/2013/11/drug-information-update-fda-drug-safety.html. Thank you for your attention.